News summary

Effects of a 12-week unsupervised and adapted physical activity prescription on physical per-formance in geriatric outpatients with overweight or obesity: the PACE tool

Source: medRxiv • Published: 10 Sept 2026, 00:00

Summarized by Masters of Longevity from medRxiv.

Report on a 12-week unsupervised home-based physical activity prescription for overweight or obese frail geriatric outpatients and its effects on lower-limb performance and sarcopenia indicators.

Effects of a 12-week unsupervised and adapted physical activity prescription on physical per-formance in geriatric outpatients with overweight or obesity: the PACE tool
Key Takeaways
  • Participants averaged 238 minutes per week of physical activity and 65% met recommended guidelines.
  • Lower-limb muscle function and endurance improved significantly after the 12-week intervention.
  • Prevalence of probable sarcopenia decreased significantly following the program.
Read the full article at medRxiv

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.